{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:51Z","timestamp":1792783431015,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science and Technology Major Project for New Drugs of\u2002the\u2002Ministry\u2002of\u2002Science\u2002and\u2002Technology\u2002of\u2002China","award":["2019ZX09734001-002-004"],"award-info":[{"award-number":["2019ZX09734001-002-004"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471615"],"award-info":[{"award-number":["81471615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601430"],"award-info":[{"award-number":["81601430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical and health science and technology innovation project of Chinese Academy of Medical Sciences","award":["2019-I2M-2-008"],"award-info":[{"award-number":["2019-I2M-2-008"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10067-020-05339-2","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T01:02:38Z","timestamp":1597366958000},"page":"999-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis"],"prefix":"10.1007","volume":"40","author":[{"given":"Jingjing","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-9898","authenticated-orcid":false,"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"issue":"1","key":"5339_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/archdermatol.2009.323","volume":"146","author":"RD Sontheimer","year":"2010","unstructured":"Sontheimer RD (2010) Clinically amyopathic dermatomyositis: what can we now tell our patients. Arch Dermatol 146(1):76\u201380. https:\/\/doi.org\/10.1001\/archdermatol.2009.323","journal-title":"Arch Dermatol"},{"issue":"5","key":"5339_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1684\/ejd.2019.3634","volume":"29","author":"SI Motegi","year":"2019","unstructured":"Motegi SI, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M, Ikeuchi H, Sakairi T, Hara K, Yamaguchi K, Maeno T, Hiromura K, Ishikawa O (2019) Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease. Eur J Dermatol 29(5):511\u2013517. https:\/\/doi.org\/10.1684\/ejd.2019.3634","journal-title":"Eur J Dermatol"},{"issue":"3","key":"5339_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/14397595.2015.1091155","volume":"26","author":"Y Yamasaki","year":"2016","unstructured":"Yamasaki Y, Satoh M, Mizushima M, Okazaki T, Nagafuchi H, Ooka S, Shibata T, Nakano H, Ogawa H, Azuma K, Maeda A, Tonooka K, Ito H, Takakuwa Y, Inoue M, Mitomi H, Kiyokawa T, Tsuchida K, Matsushita H, Mikage H, Murakami Y, Chan JY, Ozaki S, Yamada H (2016) Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52. Mod Rheumatol 26(3):403\u2013409. https:\/\/doi.org\/10.3109\/14397595.2015.1091155","journal-title":"Mod Rheumatol"},{"issue":"3","key":"5339_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","volume":"72","author":"DF Fiorentino","year":"2015","unstructured":"Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L (2015) Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis. J Am Acad Dermatol 72(3):449\u2013455. https:\/\/doi.org\/10.1016\/j.jaad.2014.12.009","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"5339_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-015-8496-5","volume":"51","author":"Y Muro","year":"2016","unstructured":"Muro Y, Sugiura K, Akiyama M (2016) Cutaneous manifestations in dermatomyositis: key clinical and serological features-a comprehensive review. Clin Rev Allergy Immunol 51(3):293\u2013302. https:\/\/doi.org\/10.1007\/s12016-015-8496-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"5339_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/art.40895","volume":"71","author":"A Aussy","year":"2019","unstructured":"Aussy A, Fr\u00e9ret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Hu\u00eb S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O (2019) The IgG2 isotype of anti-transcription intermediary factor 1\u03b3 autoantibodies is a biomarker of cancer and mortality in adult dermatomyositis. Arthritis Rheumatol 71(8):1360\u20131370. https:\/\/doi.org\/10.1002\/art.40895","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"5339_CR7","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","volume":"53","author":"T Gono","year":"2014","unstructured":"Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, Takagi K, Ichida H, Katsumata Y, Ota Y, Kawasumi H, Yamanaka H (2014) Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology (Oxford) 53(12):2196\u20132203. https:\/\/doi.org\/10.1093\/rheumatology\/keu258","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"5339_CR8","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1093\/rheumatology\/kez253","volume":"58","author":"MJS Parker","year":"2019","unstructured":"To F, Parker MJS, Vent\u00edn-Rodr\u00edguez C, Lilleker JB, Chinoy H (2019) Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria. Rheumatology (Oxford) 58(12):2331\u20132333. https:\/\/doi.org\/10.1093\/rheumatology\/kez253","journal-title":"Rheumatology (Oxford)"},{"key":"5339_CR9","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s10067-020-04984-x","volume":"39","author":"K Asakawa","year":"2020","unstructured":"Asakawa K, Yoshizawa K, Aoki A, Kimura Y, Tanaka T, Ohashi K, Hayashi M, Kikuchi T, Sato S, Takada T (2020) Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies. Clin Rheumatol 39:2171\u20132178. https:\/\/doi.org\/10.1007\/s10067-020-04984-x","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5339_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/rheumatology\/kez301","volume":"59","author":"S Matsuda","year":"2020","unstructured":"Matsuda S, Kotani T, Ishida T, Fukui K, Fujiki Y, Suzuka T, Nagai K, Hata K, Shoda T, Isoda K, Ito Y, Makino S, Takeuchi T, Arawaka S (2020) Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis\/dermatomyositis-interstitial lung disease. Rheumatology (Oxford) 59(2):310\u2013318. https:\/\/doi.org\/10.1093\/rheumatology\/kez301","journal-title":"Rheumatology (Oxford)"},{"key":"5339_CR11","doi-asserted-by":"publisher","unstructured":"Allenbach Y, Uzunhan Y, Toquet S, Leroux G, Gallay L, Marquet A, Meyer A, Guillaud C, Limal N, Gagnadoux F, Hervier B, Borie R, Deligny C, Terrier B, Berezne A, Audia S, Champtiaux N, Devilliers H, Voermans N, Diot E, Servettaz A, Marhadour T, Castelain V, Humbert S, Blanchard-Delaunay C, Tieulie N, Charles P, Gerin M, Mekinian A, Priou P, Meurice JC, Tazi A, Cottin V, Miyara M, Grange B, Isra\u00ebl-Biet D, Phin-Huynh S, Bron C, De Saint ML, Fabien N, Mariampillai K, Nunes H, Benveniste O (2020) Different phenotypes in dermatomyositis associated with anti-MDA5 antibody. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000009727","DOI":"10.1212\/WNL.0000000000009727"},{"issue":"7","key":"5339_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/nejm197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347. https:\/\/doi.org\/10.1056\/nejm197502132920706","journal-title":"N Engl J Med"},{"issue":"4","key":"5339_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness. J Am Acad Dermatol 46(4):626\u2013636. https:\/\/doi.org\/10.1067\/mjd.2002.120621","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"5339_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1164\/rccm.200412-1756OC","volume":"172","author":"DA Lynch","year":"2005","unstructured":"Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE Jr, Bradford WZ, Schwartz DA, Richard Webb W, Idiopathic Pulmonary Fibrosis Study G (2005) High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 172(4):488\u2013493. https:\/\/doi.org\/10.1164\/rccm.200412-1756OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 11 (0 11)","key":"5339_CR15","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 63(Suppl 11 (0 11)):S118\u2013S157. https:\/\/doi.org\/10.1002\/acr.20532","journal-title":"Arthritis Care Res"},{"issue":"6","key":"5339_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/bjd.17079","volume":"179","author":"M Chen","year":"2018","unstructured":"Chen M, Quan C, Diao L, Xue F, Xue K, Wang B, Li X, Zhu X, Zheng J, Cao H (2018) Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis. Br J Dermatol 179(6):1334\u20131341. https:\/\/doi.org\/10.1111\/bjd.17079","journal-title":"Br J Dermatol"},{"issue":"10","key":"5339_CR17","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","volume":"49","author":"P Szodoray","year":"2010","unstructured":"Szodoray P, Alex P, Knowlton N, Centola M, Dozmorov I, Csipo I, Nagy AT, Constantin T, Ponyi A, Nakken B, Danko K (2010) Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand. Rheumatology (Oxford) 49(10):1867\u20131877. https:\/\/doi.org\/10.1093\/rheumatology\/keq151","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5339_CR18","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1074\/jbc.M005652200","volume":"276","author":"P Loetscher","year":"2001","unstructured":"Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I (2001) The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 276(5):2986\u20132991. https:\/\/doi.org\/10.1074\/jbc.M005652200","journal-title":"J Biol Chem"},{"issue":"3","key":"5339_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1212\/wnl.0000000000001767","volume":"85","author":"A Uruha","year":"2015","unstructured":"Uruha A, Noguchi S, Sato W, Nishimura H, Mitsuhashi S, Yamamura T, Nishino I (2015) Plasma IP-10 level distinguishes inflammatory myopathy. Neurology 85(3):293\u2013294. https:\/\/doi.org\/10.1212\/wnl.0000000000001767","journal-title":"Neurology"},{"issue":"1","key":"5339_CR20","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.7417\/ct.2015.1810","volume":"166","author":"F Limongi","year":"2015","unstructured":"Limongi F (2015) The CXCR3 chemokines in inflammatory myopathies. Clin Ter 166(1):e56\u2013e61. https:\/\/doi.org\/10.7417\/ct.2015.1810","journal-title":"Clin Ter"},{"issue":"4","key":"5339_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1365-2230.2006.02150.x","volume":"31","author":"J Wenzel","year":"2006","unstructured":"Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, T\u00fcting T (2006) Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 31(4):576\u2013582. https:\/\/doi.org\/10.1111\/j.1365-2230.2006.02150.x","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"5339_CR22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/rheumatology\/ker146","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Watson KD, Lunt M, Symmons DP (2011) The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 50(7):1341\u20131342. https:\/\/doi.org\/10.1093\/rheumatology\/ker146","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5339_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2007.083188","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, Dougados M, Gossec L (2009) Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials. Ann Rheum Dis 68(1):25\u201332. https:\/\/doi.org\/10.1136\/ard.2007.083188","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5339_CR24","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/s41564-019-0578-3","volume":"4","author":"DX Ji","year":"2019","unstructured":"Ji DX, Yamashiro LH, Chen KJ, Mukaida N, Kramnik I, Darwin KH, Vance RE (2019) Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra. Nat Microbiol 4(12):2128\u20132135. https:\/\/doi.org\/10.1038\/s41564-019-0578-3","journal-title":"Nat Microbiol"},{"issue":"2","key":"5339_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2169\/internalmedicine.39.128","volume":"39","author":"K Son","year":"2000","unstructured":"Son K, Tomita Y, Shimizu T, Nishinarita S, Sawada S, Horie T (2000) Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. Intern Med 39(2):128\u2013135. https:\/\/doi.org\/10.2169\/internalmedicine.39.128","journal-title":"Intern Med"},{"issue":"12","key":"5339_CR26","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1212\/wnl.58.12.1779","volume":"58","author":"JL De Bleecker","year":"2002","unstructured":"De Bleecker JL, De Paepe B, Vanwalleghem IE, Schr\u00f6der JM (2002) Differential expression of chemokines in inflammatory myopathies. Neurology 58(12):1779\u20131785. https:\/\/doi.org\/10.1212\/wnl.58.12.1779","journal-title":"Neurology"},{"issue":"2","key":"5339_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J (2020) Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol 82(2):267\u2013281. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1309","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"5339_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13075-020-02160-9","volume":"22","author":"H Kim","year":"2020","unstructured":"Kim H, Gunter-Rahman F, McGrath JA, Lee E, de Jesus AA, Targoff IN, Huang Y, O\u2019Hanlon TP, Tsai WL, Gadina M, Miller FW, Goldbach-Mansky R, Rider LG (2020) Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res Ther 22(1):69\u201369. https:\/\/doi.org\/10.1186\/s13075-020-02160-9","journal-title":"Arthritis Res Ther"},{"key":"5339_CR29","doi-asserted-by":"crossref","unstructured":"Dourmishev LA, Dourmishev AL (2009) Dermatomyositis: advances in recognition, understanding and management.Springer,Verlag Berlin Heidelberg","DOI":"10.1007\/978-3-540-79313-7"},{"key":"5339_CR30","unstructured":"Miller FW, Oddis CV (2012) Vasculitis in the Idiopathic Inflammatory Myopathies. In: Hoffman GS (ed) Inflammatory Diseases of Blood Vessels. Wiley, New York, pp 433-440"},{"issue":"5","key":"5339_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/rheumatology\/key386","volume":"58","author":"N Ono","year":"2019","unstructured":"Ono N, Kai K, Maruyama A, Sakai M, Sadanaga Y, Koarada S, Inoue T, Tada Y (2019) The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients. Rheumatology (Oxford) 58(5):786\u2013791. https:\/\/doi.org\/10.1093\/rheumatology\/key386","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"5339_CR32","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/jcmm.12864","volume":"20","author":"T Asdonk","year":"2016","unstructured":"Asdonk T, Steinmetz M, Krogmann A, Str\u00f6cker C, Lahrmann C, Motz I, Paul-Krahe K, Flender A, Schmitz T, Barchet W, Hartmann G, Nickenig G, Zimmer S (2016) MDA-5 activation by cytoplasmic double-stranded RNA impairs endothelial function and aggravates atherosclerosis. J Cell Mol Med 20(9):1696\u20131705. https:\/\/doi.org\/10.1111\/jcmm.12864","journal-title":"J Cell Mol Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05339-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T17:30:43Z","timestamp":1667755843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05339-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5339"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05339-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study was approved by the Peking Union Medical College Hospital Ethics Committee according to the principles of the Declaration of Helsinki, and informed consent was obtained from each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}